G
Giuseppe Realdi
Researcher at University of Padua
Publications - 167
Citations - 6068
Giuseppe Realdi is an academic researcher from University of Padua. The author has contributed to research in topics: Hepatitis & Hepatitis B virus. The author has an hindex of 37, co-authored 167 publications receiving 5878 citations. Previous affiliations of Giuseppe Realdi include Baylor College of Medicine & University of Pavia.
Papers
More filters
Journal ArticleDOI
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection
Giuseppe Realdi,A. Alberti,Massimo Rugge,Flavia Bortolotti,A. M. Rigoli,Federico Tremolada,Arturo Ruol +6 more
TL;DR: In HB s Ag-positive chronic active hepatitis presence of HB e Ag in serum identifies an early, although prolonged, phase of active virus replication that is frequently followed by the disappearance of complete virus particles from serum and appearance of anti-HB e .
Journal ArticleDOI
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
Giovanna Fattovich,Giuliano Giustina,Erik Christensen,M. Pantalena,Irene Zagni,Giuseppe Realdi,Solko W. Schalm +6 more
TL;DR: HDV infection increases the risk for HCC threefold and for mortality twofold in patients with cirrhosis type B.
Journal ArticleDOI
Natural history and prognostic factors for chronic hepatitis type B.
Giovanna Fattovich,L. Brollo,G. Giustina,Franco Noventa,P Pontisso,A. Alberti,Giuseppe Realdi,Arturo Ruol +7 more
TL;DR: Findings indicate that patients with severe chronic active hepatitis and persistent hepatitis B virus replication are at very high risk of rapid progression to cirrhosis.
Journal ArticleDOI
Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
Giovanna Fattovich,Massimo Rugge,L. Brollo,P Pontisso,Franco Noventa,Maria Guido,A. Alberti,Giuseppe Realdi +7 more
TL;DR: Findings indicate that, in chronic hepatitis type B, termination of virus replication is associated in most patients with biochemical and histologic regression of inflammatory activity, and after anti‐HBe seroconversion has occurred, virus replication and liver disease may persist or reactivate in a small proportion of patients thus giving origin to the well‐recognized group of anti-HBe positive, hepatitis B virus DNA‐positive chronic hepatitistype B.
Journal ArticleDOI
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach.
Maria Pina Dore,Maria Pina Dore,Gioacchino Leandro,Gioacchino Leandro,Giuseppe Realdi,Giuseppe Realdi,Antonia R. Sepulveda,Antonia R. Sepulveda,David Y Graham,David Y Graham +9 more
TL;DR: In conclusion, metronidazole or clarithromycin pretreatment resistant H. pylori are the main factors responsible for treatment failure with regimens using these compounds.